1Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
2Division of Pulmonary and Critical Care, The Jane and Leonard Korman Respiratory Institute, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Popul Health Manag. 2019 Aug;22(4):347-361. doi: 10.1089/pop.2018.0128. Epub 2018 Nov 8.
Patient navigation has been proposed to combat cancer disparities in vulnerable populations. Vulnerable populations often have poorer cancer outcomes and lower levels of screening, adherence, and treatment. Navigation has been studied in various cancers, but few studies have assessed navigation in lung cancer. Additionally, there is a lack of consistency in metrics to assess the quality of navigation programs. The authors conducted a systematic review of published cancer screening studies to identify quality metrics used in navigation programs, as well as to recommend standardized metrics to define excellence in lung cancer navigation. The authors included 26 studies evaluating navigation metrics in breast, cervical, colorectal, prostate, and lung cancer. After reviewing the literature, the authors propose the following navigation metrics for lung cancer screening programs: (1) screening rate, (2) compliance with follow-up, (3) time to treatment initiation, (4) patient satisfaction, (5) quality of life, (6) biopsy complications, and (7) cultural competency.
患者导航被提议用于解决弱势群体中的癌症差异问题。弱势群体的癌症预后往往较差,筛查、依从性和治疗水平也较低。导航已在各种癌症中进行了研究,但很少有研究评估肺癌中的导航。此外,用于评估导航计划质量的指标缺乏一致性。作者对已发表的癌症筛查研究进行了系统评价,以确定导航计划中使用的质量指标,并建议标准化指标来定义肺癌导航的卓越性。作者纳入了 26 项评估乳腺癌、宫颈癌、结直肠癌、前列腺癌和肺癌导航指标的研究。在审查文献后,作者提出了以下用于肺癌筛查计划的导航指标:(1)筛查率,(2)随访依从性,(3)开始治疗的时间,(4)患者满意度,(5)生活质量,(6)活检并发症,以及(7)文化能力。